期刊文献+

内源分泌型高级糖基化终末产物受体与冠心病危险因素对动脉弹性的影响 被引量:3

The influence of serum endogenous secretory advanced glycation endproducts receptor and CAD risk factors on arterial elasticity
下载PDF
导出
摘要 目的探讨冠心病患者内源分泌型高级糖基化终末产物受体(esRAGE)与冠心病危险因素对动脉弹性的影响。方法选择180例冠心病患者,检测颈-股动脉脉搏波传导速度(cf-PWV)、肱-踝动脉脉搏波传导速度(ba-PWV)和血esRAGE,分析与冠心病相关的危险因素。结果与未合并高血压、糖尿病、腰围正常和≤3个异常代谢组分患者比较,合并高血压、糖尿病、腰围异常和>3个异常代谢组分患者的cf-PWV、ba-PWV明显增高,血esRAGE降低(P<0.05)。log cf-PWV与年龄、收缩压、舒张压、稳态模式评估法胰岛素抵抗指数呈正相关,与esRAGE呈负相关(P<0.05)。ba-PWV与年龄、收缩压、舒张压呈正相关,与esRAGE呈负相关(P<0.05)。log cf-PWV与年龄、收缩压、esRAGE独立相关;ba-PWV与年龄、收缩压独立相关。结论合并危险因素的冠心病患者的动脉弹性功能明显减低,冠心病患者esRAGE水平下降在动脉弹性减低方面起着重要作用。 Objective To analyze the influence of serum endogenous secretory advanced glycation end-products receptor(esRAGE) and coronary artery disease(CAD) risk factors on arterial elasticity in patients with CAD. Methods 180 patients with CAD diagnosed by coronary angiography were enrolled. Arterial elasticity parameters(cf-PWV, ba-PWV) and cardiometabolic risk factors were measured in all patients. The relationships of serum esRAGE and cardiometabolic risk factors with arterial elasticity were analyzed. Results Patients with more than 3 types of cardiometa- bolic risk factors had higher cf-PWV, ba-PWV and lower esRAGE than those with less risk factors (P 〈 0.05). Log cf-PWV was positively correlated to age, blood pressure and log HOMA (insulin resistance index) ; ba-PWV was positively correlated with age and blood pressure. Both cf-PWV and ba-PWV were negatively correlated with esRAGE. Multi-factor regression analysis showed that age, SBP and esRAGE independently correlated with log cf-PWV. Age and SBP were independently correlated with ba-PWV. Conclusion Cardiometabolic risk factors can induce abnormal arterial elasticity. Low circulating esRAGE level plays an important role in the decrease in arterial elasticity in patient with CAD.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第9期813-816,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 糖基化终产物 高级 冠心病 高血压 糖尿病 肥胖症 血脂异常 危险因素 glycosylation end products, advanced coronary disease hypertension diabetes mellitus obesity dyslipidemias risk factors
  • 相关文献

参考文献2

二级参考文献40

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献611

同被引文献19

  • 1连乐燊,陈汉锐,郑创华,吴启端.瓜蒌薤白类方与心血管系统相关的研究概况[J].中医药学刊,2006,24(7):1345-1346. 被引量:22
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2065
  • 3Raison J, Rudniehi A, Safar ME,et al. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hyper- cholesterolaemia[J]. Human Hypertension, 2002, 16 (10) : 705 - 710.
  • 4Motobe K, Tomiyarna H, Koji Y,et al. Cut - off value of the ankle- b ra- chial pressure index at which the accuracy of brachial - ankle pulse wave velocity measurement is diminished[J]. Circ J, 2005,69 (1) : 55 - 60.
  • 5Aso K,Miyata M,Kubo T,etal. Brachial ankle pulse wave velocity is useful for evaluation of complications in type2 diabetic patients [J]. Hypertens Res,2003,26(10) :807 - 813.
  • 6Mitchell GF, Parise H, Beniamin EJ ,et al. Changes in arterial stiff- ness and wave reflection with advancing age in healthy men and women. The Framingham Heart Study[J]. Hypertension,2004,43 (6) :1239- 1245.
  • 7Rosa J, Strauch B, Petrdkl O. Relationship between clinical, 24 - hour, average day - time and night - time blood pressure and measures of arterial stiffness in essential hypertension[J]. Physi oi,2008,57(2) :303 - 306.
  • 8Mitchell GF, Hwang SJ,Vasan RS,et al. Arterial stiffness and car- diovascular events: The Framingham Heart Study[J]. Circulation, 2010,121(4) :505- 511.
  • 9Sakuragi S, Lwasaki J, Tokunaga N, et al. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease[J]. Cardiology,2005,103(2): 107 - 112.
  • 10Laurent S, Katsahiat: S, Fassot S, et al. Aortic stiffness is an inde- pendent predictor of fatal stroke in essential hypertension[J]. Stroke, 2003,34 : 1203 - 1206.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部